TriSalus Life Sciences, Inc. (TLSI) Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies Transcript

Company Overview - TriSalus Life Sciences is focused on improving outcomes for patients with solid tumors, specifically in the liver and pancreas [2] - The company utilizes a platform technology that modulates pressure and flow to enhance therapy delivery directly into tumors while minimizing off-target effects [2] Innovative Approach - Dr. Juan Camacho has developed a new approach for Thyroid Artery Embolization, which is part of TriSalus's innovative strategies [2]